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Abstract 
It is acknowledged that people with a schizophrenia-spectrum diagnosis experience higher levels of 
stigma compared to any other mental health diagnosis.  As a consequence, their experience of 
internalised stigma is likely to be the most detrimental and pervasive.  Internalised stigma 
interventions have shown some benefits in those who experience serious mental illness including 
those diagnosed with a schizophrenia-spectrum diagnosis.  A systematic narrative review and meta-
analysis were conducted examining the efficacy of internalised stigma interventions for people with 
a schizophrenia-spectrum diagnosis.  Randomised Controlled Trials, controlled trials, and cohort 
studies were included and assessed against quality criteria.    The search identified 12 studies; 7 
randomised controlled trials, 3 cohort studies and 2 controlled trials.  A variety of psychosocial 
interventions were utilised with the majority employing Cognitive Behaviour Therapy (CBT), 
psychoeducation and social skills training.  The core outcomes used to examine the efficacy of the 
intervention were internalised stigma, self-esteem, empowerment, and functioning. The meta-
analysis revealed an improvement in internalised stigma favouring the internalised stigma 
intervention but was not significant (5 RCTs, n=200).  Self-efficacy and insight were significantly 
improved favouring the internalised stigma intervention.  Internalised stigma interventions show 
promise in those with schizophrenia-spectrum diagnoses.  Existing interventions have demonstrated 
small effects and employed small samples. Large scale RCTs are required to further develop the 
evidence base of more targeted interventions.    
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Introduction  
 
Stigma was originally defined as an “attribute that is deeply discrediting” which turns a person from 
“a whole and usual person to a tainted, discounted one”, page 3(Goffman, 1963).  Stigma is 
pervasive amongst people diagnosed with a mental health difficulty in our current society (Wood et 
al., 2014). Corrigan and Watson (2002) explained that stigma comprises two distinct components; 
public stigma and self-stigma.  Public stigma consists of negative stereotypes (a specific negative 
belief about a group), prejudice (agreement with belief) and discrimination (negative behavioural 
response) from the public towards the stigmatised group.  Self-stigma, often described as 
internalised stigma interchangeably, is becoming aware of the negative stereotypes, agreeing with it 
and applying it to one’s self (Corrigan et al., 2010).  The term internalised stigma will be used 
henceforth throughout this review.  Internalised stigma can be extremely detrimental to service 
users who experience severe mental illness (SMI).  Livingston and Boyd (2010) conducted a 
systematic review of the consequences of internalised stigma and found that it was associated with 
poorer self-esteem, hopelessness, reduced self-efficacy and disempowerment.  It can also 
exacerbate existing mental health problems, increase social avoidance and impair recovery(Corrigan 
and Watson, 2002).  
 
Arguably, those with a schizophrenia-spectrum diagnosis experience higher levels of internalised 
stigma compared to other SMI diagnoses (Holzinger et al., 2003). A number of large-scale studies 
have identified that those diagnosed with schizophrenia are viewed most negatively by the public 
(Wood et al, 2014), experienced the most discrimination (Dinos et al., 2004), and experience the 
most rejection (Lundberg et al., 2008).  High levels of  internalised stigma were reported by almost of 
half (41.7%) of a large European sample of people with a schizophrenia-spectrum diagnosis and two 
thirds (69.4%) reported moderate or high perceived discrimination (Brohan et al., 2010a).  
Moreover, compared to bipolar disorder, people diagnosed with schizophrenia reported significantly 
higher rates of internalised stigma with significant impacts on their social life and overall functioning 
(Karidi et al., 2015; Sarisoy et al., 2013).   Furthermore, in a large sample (n=261), internalised stigma 
was identified as conceptually different in schizophrenia compared to depression and bipolar 
disorders (Oliveria et al., 2015).  Internalised stigma in schizophrenia was characterised by 
dissatisfaction with social relationships, high levels of stereotyping, withdrawal and alienation 
(Oliveria et al., 2015).  Furthermore, they found that internalised stigma was a risk factor for social 
isolation only in individuals with schizophrenia, which may worsen the course of the disorder. 
There is an increasing interest in the development of interventions to reduce internalised stigma.   A 
number of pilot studies and small scale trials have been conducted examining the efficacy of these 
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interventions.  These studies have found some promising finding such as significant improvements in 
engulfment, hopelessness, quality of life, self-esteem and personal recovery (Fung et al., 2011; 
McCay et al., 2007; Morrison et al., 2015). However, a number of these studies have reported no 
impact on their primary outcome measures of internalised stigma and other secondary outcomes  
(Fung et al., 2011; Link et al., 2002; Morrison et al., 2015; Yanos et al., 2012) .  
A handful of systematic reviews have been conducted examining the efficacy of internalised stigma 
interventions for SMI. Although the evidence base is relatively small, examination of studies which 
meet rigorous criteria for inclusion in a systematic review and meta-analysis allows conclusions to be 
drawn regarding the efficacy of such interventions (Moher et al., 2009).   Griffiths et al. (2014) 
conducted a systematic review of three randomised controlled trials (RCTs) of internalised stigma 
interventions for SMI (Fung et al., 2011; Luoma et al., 2012; Yanos et al., 2012) but their pooled 
mean effect sizes were not statistically significant.  Two further systematic reviews conducted by 
Mittal et al. (2014) and Yanos et al. (2014) examined internalised stigma interventions for SMI using 
a narrative synthesis methodology.  Mittal et al. (2014) reported that only two of seven studies 
examining participants with a diagnosis of schizophrenia-spectrum diagnosis reported significant 
improvements post intervention. Yanos et al (2014) examined internalised stigma interventions in 
detail and considered their effective change mechanisms.  They concluded that psychoeducation and 
cognitive challenging were the most important elements of an intervention.    Both reviews did not 
follow rigorous criteria for the conduct of systematic reviews and meta-analysis as outlined by, for 
example, the Cochrane Collaboration (Higgins and Green, 2011).   
The use of meta-analysis with small, potentially heterogeneous studies is a topic of much debate.  
The systematic review and meta-analysis of small studies has been illustrated to increase 
methodological heterogeneity, error rates, and the chances of identifying a false statistically 
significant finding (Borenstein et al., 2009; IntHoult et al., 2015; IntHout et al., 2012) However, in an 
area with a limited evidence base, the meta-analysis of small studies can provide informative effect 
sizes as long as sensitivity analyses is considered (Borenstein et al., 2009; IntHoult et al., 2015).  To 
date, no systematic reviews have been conducted examining the efficacy of internalised stigma 
interventions for people with a schizophrenia-spectrum diagnosis.  It is important that such 
interventions are examined within a systematic review in order to determine whether they are 
efficacious in this population.  There has been no examination of study quality and risk of bias of 
internalised stigma intervention studies.  Furthermore, a narrative exploration of change mechanism 
would offer important information on what may bring about change in internalised stigma 
interventions. There also appears to be no agreement on outcome measures used to assess the 
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efficacy of an internalised stigma intervention. Finally, data from internalised stigma RCTs have not 
been subject to a meta-analysis to examine for overall efficacy.  Given the limited literature, a 
systematic narrative review (Colliver et al., 2008) and meta-analysis will be conducted.  The review 
will aim to examine study quality and risk of bias of included trials, compare and contrast 
internalised stigma interventions for their key mechanisms of change, and scrutinise study outcomes 
and measures used to assess outcome.  The meta-analysis will aim to examine the efficacy of the 
internalised stigma interventions on the primary outcome of internalised stigma, and other 
secondary outcomes. 
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Methodology 
Study protocol 
The review protocol was published online at the PROSPERO website on the 25th November 2014 
(http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014015161#.VLflgNEfzIU).  
 
Inclusion and exclusion Criteria 
This review included studies (a) where ≥50% of participants meet criteria for (i) a schizophrenia-
spectrum diagnoses (schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional 
disorder, psychotic disorder not otherwise specified defined by any criteria) or (ii) threshold for Early 
Intervention in Psychosis services (to allow for diagnostic uncertainty), in order to ensure the sample 
was primarily those with a schizophrenia spectrum diagnosis or psychosis presentation (b) which 
examined internalised stigma or self-stigma as an outcome (c) which examined a psychosocial 
intervention which aimed to reduce internalised stigma (d) in English language, (e) with a sample of 
adults aged 16–65 (f) with a randomised control trial (RCT), controlled trial (CT) or cohort study (CS) 
(an observational study which follows participants over time) (CS) (g) of effectiveness and efficacy.   
Exclusion criteria were defined by (a) studies which include ≥50% of participants with psychosis as a 
secondary diagnosis (e.g. to alcohol use, learning disability) (b) observational studies. No criteria are 
specified in regard to severity and/or duration of illness.   
 
Search strategy 
Three electronic databases, Embase, Medline and PsycInfo were utilised for the search.  Two trial 
registries were also examined, the Cochrane Central Register of Controlled Trials (CENTRAL) and the 
Clinical Trials registry, to identify any unpublished or soon to be published studies in peer review 
journals. The initial search was conducted between November 2014 and March 2015 by the first 
author (LW) using the following key words:  (Schizo* OR psychosis OR psychotic OR Delusion* OR 
Voices OR Hallucinat* OR Mental Illness) AND (Stigma) AND (Intervention OR Therapy OR CBT OR 
Trial). Initially titles and abstracts were screened.  For relevant studies full texts were sourced.  
Authors of conference abstracts were followed-up.  All corresponding authors of the final studies 
included were contacted to identify any further published or unpublished work.  References of 
included studies were also examined for any further papers.  Recent reviews examining internalised 
stigma for SMI, Livingston and Boyd (2010), Mittal et al(2014), Yanos et al(2014) and Griffiths et 
al(2014) were also examined for relevant studies.   
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Data extraction 
Individual study data was extracted by the first author (LW) into pre-defined tables with 
uncertainties discussed with AM and RB.  RB crosschecked 25% of data extraction and no errors 
were identified.  A number of study characteristics were extracted, including type of intervention, 
intervention modality (group or  individual therapy), duration of treatment, number of prescribed 
sessions,  duration of treatment period (weeks), control condition (e.g. treatment as usual), number 
of arms of study, demographics (age, gender, diagnosis), consent rates, dropout rates, percentage of 
participants who had the full amount of sessions, length of sessions, and pertinent statistical 
information (means, standard deviation, N from each assessment time point (e.g. baseline, post 
therapy, follow-up points) on specific outcomes of interest.    Analysis of any available relapse, 
rehospitalisation and adverse events was also extracted. If any data were not available in the 
published report, corresponding authors were contacted.  The above data were obtainable from the 
majority of studies.  Two studies (Link et al., 2002; McCay et al., 2007) were unable to provide usable 
data for meta-analysis, but these reports still contributed to the narrative synthesis of the review.    
 
Methodological quality and risk of bias of included studies 
A detailed examination of the quality of the studies was undertaken using the Effective Public Health 
Practice Project (EPHPP) tool (Armiji-Olivo et al., 2012).  This tool was chosen over the GRADE risk of 
bias tool (Higgins et al., 2011), which was outlined in our submitted proposal,  as it allowed 
assessment of quantitative studies with a variety of methodologies.  It examined six key areas of 
potential bias; selection bias, study design, confounders, blinding, data collection methods, and 
withdrawals and dropouts (see measure for more detail).   Studies can score weak, moderate or 
strong with weak scores illustrating high risk of bias and strong scores reflecting a low risk of bias.  
Quality assessments were carried out by the first author (LW) and were reviewed with other authors 
in supervision (AM, RB).  Risk of bias assessments are outlined in table 2.   
 
Data Analysis 
The inclusion of non-RCTs meant data analysis was informed by the procedures of narrative 
synthesis (Popay et al., 2006). Narrative synthesis offered a framework for structuring a systematic 
review which includes non-RCT studies.  It outlined four key elements to the process; developing a 
theory of how the intervention works, why and for whom, developing a preliminary synthesis of 
findings of included studies, exploring relationships in the data, and assessing the robustness of the 
synthesis.  Initially, the review compared and contrasted the types of therapies employed within the 
included studies.  Individual study outcome measures were examined and described. A vote 
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counting tool, as recommended by Popay et al. (2006), was implemented to visually illustrate when 
a study reported a positive effect, a negative effect or did not report for a given outcome.   
Meta-analysis was used to integrate available effects extracted from the RCTs included in the review.  
Meta-analysis was conducted using Comprehensive Meta-Analysis (CMA) software, version 
3(Borenstein et al., 2009).  As all available data was continuous, data from different outcome 
measures were combined using the standardised mean difference, Hedges g (Higgins and Green, 
2011). Effect sizes were calculated using post therapy and follow-up data provided in the included 
studies, based on means, standard deviations and sample sizes extracted from the primary studies.   
A meta-analysis was conducted where at least two RCTs contributed to the examined outcome.   
Fung et al. (2011) was the only study with multiple follow-up points (two, four, six months) so, in 
order to be conservative, the middle follow-up point (four months) was extracted.   Where there 
was more than one measure for an examined outcome with a study, and aggregated effect was 
estimated based on the procedure outlined by Borenstein et al.(Borenstein et al., 2009).  Effects 
were integrated using a random effects model.  
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Results 
Systematic narrative review 
Study selection 
The process of study selection followed study extraction guidance from Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA)(Moher et al., 2009), as outlined in figure 1.  The 
initial search, after removing duplicates, identified 3176 papers and conference abstracts.  The 
majority of studies were excluded through title and abstract screening for being irrelevant, leaving 
20 studies.  The full-texts for these studies were sourced and examined against the inclusion and 
exclusion criteria.  This led to a total ten of studies being identified from the database searches.  Two 
further studies were identified from, (a) the reference list of an already included study (Link et al., 
2002) and (b) another identified by a contacted author(Roe et al., 2014).  A final twelve studies were 
included in the review.  Excluded studies are identified in appendix 1.    
Study characteristics 
Study characteristics and baseline demographics are outlined in table 1.  A total of seven studies 
used a RCT design (Fung et al., 2011; Link et al., 2002; McCay et al., 2007; Morrison et al., 2015; 
Rusch et al., 2014; Russinova et al., 2014; Yanos et al., 2012) and five were CTs or CSs(Knight et al., 
2006; Lucksted et al., 2011; Roe et al., 2014; Sousa et al., 2012; Uchino et al., 2012).  All studies were 
relatively small with the biggest sample including sixty six participants. Only four studies included 
participants exclusively with a schizophrenia-spectrum diagnosis.  In terms of these participants, ten 
studies examined those with SMI, one included a combination of SMI and early onset presentations, 
and one examined first episode psychosis only.  The majority of participants were male and middle 
aged.  All studies were conducted in outpatient settings.     
Risk of bias 
All studies were assessed for bias using the EPHPP tool.  Summary scores and ratings are outlined in 
table 2.  All studies were assessed on six key areas outlined by the EPHPP tool; selection bias, study 
design, confounders, blinding, data collection, withdrawals and dropouts (Armiji-Olivo et al., 2012).  
Selection bias was examined and only one study rated strongly in this category as they sampled 
participants from a variety of services (Morrison et al., in press), whereas all other studies were 
either not randomised and/or recruited participants from one or two clinics, and therefore scored 
moderately.   All RCTs were rated as strongly on study design because investigators would have no 
way of predicting the allocation of participants to groups thus minimising bias.  The CTs were rated 
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moderate as they had a control group; however participants were not randomly allocated.  All other 
studies which did not have a control group were rated as weak.  The RCTs also scored strongly on 
confounders, except Link et al. (2002) as confounders were not described.  All other studies scored 
weakly on this variable as confounders were not controlled for in the design or data analysis.  Only 
two RCTs explicitly described blinding procedures, either in their published paper or through further 
contact with the author, whereas all the other papers did not comment on blinding procedures.  All 
other studies were unblinded so were scored weakly.  All studies scored strongly on data collection 
methods as they all employed widely used outcome measures which have been validated with 
people who experience SMI.   All RCTs, except Yanos et al(2012) and Link et al(2002), rated strongly 
on drop outs.  One CTs rated as weak on this factor with over 50% of drop outs (Roe et al., 2014), the 
rest of the studies rated moderately.   Overall, the global ratings of bias expectedly found the RCTs 
as strong and all other studies as weak.   
 
Characteristics of self-stigma interventions used 
The average number of sessions offered by the RCTs was 12.71 sessions (range 3 – 20), and 11.4 
(range 6-20) by other studies. The majority of studies included in this review utilised a group format 
intervention (91.67%) and one study offered individual therapy (Morrison et al., 2015).  The majority 
of studies (66.67%) used some form of psychoeducation and/or CBT.  Two studies explicitly 
identified their therapeutic intervention as Cognitive Behaviour Therapy (CBT) as the basis of their 
intervention (Knight et al., 2006; Morrison et al., 2015).  Knight et al. (2006) drew upon two main 
cognitive models for their CBT intervention; group treatment for auditory hallucinations (Wykes et 
al., 1999) and, ‘I am super’ group treatment for self-esteem (Lecomte et al., 1999).  Morrison et al’s 
(2015) 12 session intervention was underpinned by the CBT for psychosis theoretical model 
(Morrison, 2001) and used techniques from Morrison et al’s (2008) self-help manual.   
Two studies delivered an adapted CBT approach titled Narrative Enhancement Cognitive Therapy 
(NECT) for their group intervention(Roe et al., 2014; Yanos et al., 2012).  NECT is a 20 session 
manualised intervention based on principles of CBT but aims to help participants gain a positive 
narrative about their mental health experiences through story telling with their peers (Roe et al., 
2014).  It consisted of four modules, an introduction, psychoeducation, cognitive restructuring, and 
narrative enhancement.   
Two studies combined psychoeducation, CBT and social skills training to develop their respective 16 
session group interventions (Fung et al., 2011; Lucksted et al., 2011).  Fung et al. (2011) developed a 
therapeutic framework consisting of psychoeducation about schizophrenia, CBT for irrational ideas 
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of self-concept and abilities, motivational intervention to promote change and social skills training.  
Lucksted (2011) used CBT skill to challenge self-stigmatising thinking, strengthening positive aspects 
of self, creating a belongingness to their local community, family and friends, and responding to 
overt experiences of stigma and discrimination.   
Two studies developed peer-led group interventions (Rusch et al., 2014; Russinova et al., 2014) 
which were 3 and 10 sessions in length respectively.  Coming Out Proud (COP) (Rusch et al., 2014) is 
a 3 two hour session manualised group programme to support people with a diagnosis of mental 
illness in their decisions around disclosing their diagnosis to others.  The sessions examined 
advantages and disadvantages of disclosure, different ways to disclose and how to disclose their 
personal mental health journey in an idiosyncratic way.  The photovoice intervention (Russinova et 
al., 2014) aimed to help participants develop a personal narrative regarding stigma and 
discrimination, and means for recovery through the use of photography.  Throughout the group 
process, participants developed coping strategies for managing stigma, such as challenging stigma in 
social situations and challenging internalised stigma through strategies similar to cognitive 
restructuring. 
The remaining studies used: six session group psychoeducation to teach participants accurate non-
stigmatising perceptions of schizophrenia with an emphasis on violence and criminal activity (Uchino 
et al., 2012);  16 session group psychoeducation focusing on developing awareness of stigma, 
recognising the possibility of internalising stigma and identifying stigma in social interactions and 
learning how to cope (Link et al., 2002); 15 session group sociodrama, where participants discuss 
their experiences and understanding of stigma and act out related scenes, alongside online 
educational classes about stigma (Sousa et al., 2012); and a 12 session recovery focused group which 
helped participants develop a healthy self-concept through acceptable appraisals of psychosis, 
minimising self-stigmatising attitudes, developing hope and future goals (McCay et al., 2007).   
Characteristics of outcomes used 
Each study was examined for the outcomes utilised to measure the efficacy of their interventions.  
As this a relatively novel area, there is no agreement regarding the types of outcome measures to 
reliably assess the efficacy of an internalised stigma intervention apart from internalised stigma 
itself.  The outcome measures used by each study are outlined in table 3.   The primary outcome of 
internalised stigma was measured using a diverse number of self-report questionnaires across 
studies which arguably conceptualise internalised stigma differently.  The Internalised Stigma of 
Mental Illness (ISMI) scale (Ritsher et al., 2003) and the Chinese self-stigma scale (Fung et al., 2007) 
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are the only measures designed specifically to examine internalised stigma.  Other measures used 
such as the perceived discrimination and devaluation (PDD) scale(Link et al., 2002) and the modified 
engulfment scale(McCay and Seeman, 1998) are arguably not measuring the same construct of 
stigma.  In a systematic review of outcome measures, Brohan et al. (2010b) distinguished between 
perceived stigma (how individuals think the public perceive people with mental health difficulties, 
and they view them personally) and internalised stigma (internalisation of cognitions and emotions 
in response to public stigma) and explain how they are conceptually different.  Therefore, the PDD 
scale may be measuring aspects of both perceived and internalised stigma. Furthermore, (Brohan et 
al., 2010b) found that the PDD scale only met one (construct validity) of five reliability and validity 
criteria.    The primary measure, ISMI(Ritsher et al., 2003)  used within most of the studies met four 
(content validity, internal consistency, construct validity, test-retest reliability) of their five outlined 
criteria (not floor/ceiling effects).  Brohan et al(2010b) identified that there are no acceptable 
measures of internalised stigma currently available.   In addition, these measures have been 
validated in SMI and not specifically with those who have a schizophrenia-spectrum diagnosis which 
may experience internalised stigma differently.  Therefore, the reliability and validity of the 
internalised stigma measures is questionable. 
There was little consistency in the secondary outcomes utilised by studies.  The most frequently 
used secondary outcomes were self-esteem (50%), coping skills (41.7%), empowerment (41.7%) and 
functioning (41.7%).  In order to develop the evidence base of internalised stigma interventions, 
consistent core measures should be employed. 
Examination of primary and secondary outcomes 
Primary outcome Internalised stigma 
Internalised stigma was examined by all studies included in the review.  Both CTs and one pre/post 
CS found significant improvements in internalised stigma individually, and no RCTs found significant 
individual improvements.  A meta-analysis was conducted with five RCTs (n=200) that had available 
data (figure 2 and 3).  Analysis did not suggest a significant difference in internalised stigma between 
groups at end of therapy, although analysis was favouring the internalised stigma intervention 
(Hedges’ g 0.24, 95% CI -0.06 to 0.53, p = 0.11).  Heterogeneity between studies was low (Q=0.783, 
P=0.941, I2 = 0.000).  Similarly, at follow-up (ranging from 3 week to 4 months) there was no 
significant difference in internalised stigma between groups, although the analysis favoured the 
internalised stigma intervention (Hedges’ g 0.21, 95% CI -0.08 to 0.50, p=0.16).  Heterogeneity was 
also low for this time point (Q=0.352, P=0.986, I2  = 0.000). 
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Secondary outcomes 
In order to focus on the most important secondary outcomes, outcomes which had at least three or 
more studies contributing to an outcome were examined in the meta-analysis.  Table 4 outlines the 
outcomes examined and whether the individual studies found a significant or non-significant result 
favouring the intervention.   
The random effects models and effect sizes for the secondary outcomes are outlined in figures 4 – 7. 
RCTs examining depression, empowerment, hopelessness, recovery and self-esteem were entered 
into a meta-analysis to examine end of therapy outcome of self-esteem.  No significant findings were 
identified. 
Self-efficacy was examined by three RCTs, two found a significant improvement in self-efficacy at the 
end of therapy.  Two RCTs with available data (N= 89) were entered into a meta-analysis.  Self-
efficacy was shown to significantly favour the internalised stigma intervention following therapy 
(Hedges’ g 0.49, 95% CI 0.07 to 0.91, p=0.02).  This was not maintained at follow-up but the effect 
was favouring the intervention (Hedges’ g 0.31, 95% CI -0.10 to 0.71, p=0.14).  
Insight was examined by three studies, two RCTs and one CT.  The CT and one RCT found an 
individual significant difference favouring the intervention.  The two RCTs (N=70) were entered into 
a meta-analysis.  At the end of therapy there was a significant outcome favouring the internalised 
stigma intervention (Hedges’ g 0.43, 95% CI 0.04 to 0.83, p=0.03).  This significant treatment effect 
was not maintained at follow-up (Hedges’ g 0.28, 95% CI -0.12 to 0.68, p=0.17). 
Coping skills included outcomes which examined ways people responded and coped with stigma and 
their related mental health difficulties.  The outcomes examined varied quite considerably across 
included studies.  Studies looked at outcomes such as secrecy, withdrawal, distancing, educating, 
positive views of disclosure, problem solving and avoidance coping.  These outcomes were not 
entered into a meta-analysis due to the variability in outcomes.   
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Discussion 
This study aimed to conduct a systematic narrative review and meta-analysis of psychosocial 
interventions for internalised stigma with schizophrenia-spectrum diagnoses.  A total of 12 studies 
were included in the review, 7 RCTs, 3 CSs and 2 CTs.  This review is the first of its kind examining the 
efficacy of internalised stigma interventions specifically in schizophrenia-spectrum diagnoses.  The 
review has to be interpreted tentatively due to the relatively small number of studies with small 
sample sizes which were included.   
Examination of the interventions revealed that psychoeducation, thought challenging, connecting 
with peers and social skills training were the most commonly used techniques within the 
psychosocial interventions.  It was beyond the scope of this review to statistically examine which 
interventions significantly predicted outcome due to the paucity of studies. In a recent narrative 
review of internalised stigma interventions for SMI, Yanos et al (2014) similarly found that 
psychoeducation and cognitive challenging were key components of all interventions.   Furthermore, 
in a recent examination of service user perspectives of participation in the (Morrison et al., in press) 
internalised stigma CBT intervention, a number of specific change mechanisms were highlighted as 
essential in the therapeutic process (Wood et al., in press).  Psychoeducation and normalisation 
were identified by service users as important mechanisms within therapy. The review findings 
tentatively support the use of previously identified change mechanisms. 
Few of the interventions were specifically designed for people with a schizophrenia-spectrum 
diagnosis.  The majority of internalised stigma studies were for SMI rather than those with a 
schizophrenia-spectrum diagnosis per se.  Less than half of studies included in this review had 
specific interventions for this group.  Other studies included participants who experienced chronic 
depression, anxiety, bipolar disorder and personality disorders (Link et al., 2002; Lucksted et al., 
2011; Roe et al., 2014; Rusch et al., 2014; Russinova et al., 2014; Yanos et al., 2012).  As outlined, the 
stigma experienced by those with schizophrenia-spectrum diagnosis is likely to be conceptually 
different to those with other psychiatric diagnoses (Oliveria et al., 2015).  Moreover, psychological 
interventions are commonly developed for specific presentations in order to maximise their efficacy.  
For example, the cognitive models of psychosis (Morrison, 2001) and bipolar (Mansell, 2007) have 
distinctive differences in the conceptualisation their respective presentations. This has a number of 
potential consequences for the efficacy of the intervention as a) people with a schizophrenia-
spectrum diagnosis may have not felt as comfortable sharing their experiences with the group, 
especially if they were in the minority, and b) the intervention itself may have not been tailored to 
their specifics needs in relation to internalised stigma.   
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The Morrison et al. (in press) study was the only to offer individual CBT for internalised stigma; all 
others offered a group intervention. There are a number of advantages of an individual therapy 
which may be helpful in alleviating internalised stigma.  A particular advantage is the ability to 
develop an idiosyncratic formulation.  A formulation has been highlighted as an essential part of CBT 
by therapists ensuring that therapy goals are targeted to a service user’s individual needs (Morrison 
and Barratt, 2010).  Exploration of service user experiences of the Morrison et al. (in press) 
intervention indicated that flexible goal setting was essential to the efficacy of the intervention 
(Wood et al., in press). Further RCTs are required examining the efficacy of individual interventions 
for internalised stigma. 
The primary outcome of internalised stigma was found to be significantly improved by two CTs and 
one pre/post CS but not significant in the meta-analysis at end of therapy or follow-up.  The most 
methodologically robust study found the largest effect favouring the internalised stigma intervention 
(Morrison et al., in press). Internalised stigma has been highlighted to be extremely prevalent in 
those with mental health difficulties, including schizophrenia-spectrum diagnoses (Brohan et al., 
2010a).  It has been highlighted as an important factor negatively impacting on people’s mental 
health, self-esteem, levels of depression and hopelessness(Livingston and Boyd, 2010) and therefore 
is an important outcome to target in psychological therapy.  It is essential this is continued to be 
examined as a primary outcome in internalised stigma interventions.  
This meta-analysis identified that internalised stigma, self-esteem, and empowerment illustrated an 
overall effect favouring the internalised stigma intervention, and self-efficacy and insight had a 
significant effect after the internalised stigma intervention.  This would suggest that these outcomes 
are important in capturing the efficacy of an internalised stigma intervention.    Although the overall 
effect did not near significance for other outcomes, depression, hopelessness and recovery were 
found to have a small effect favouring the internalised stigma intervention in the Morrison et 
al(2015) study.  This study found an individual significant effect for personal recovery measured on 
the process of recovery questionnaire(Neil et al., 2009).  This study was found to be the most 
methodologically robust study with little bias detected indicating that these outcomes may also be 
important in assessing the efficacy of an internalised stigma intervention.     
One of the limitations of the review was the small studies that were included.  In a meta-analysis, 
small studies can fail to detect a modest intervention effect due to the lack of power within each 
individual studies (Borenstein et al., 2009).   Conversely, small studies can also have “small-study 
effects” as small studies are likely to suffer from publication bias and only be published if they are 
significant (Hutton and Taylor, 2014).  Small studies are also more likely to suffer from 
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methodological flaws.  This review included studies which illustrated heterogeneity although the 
small study numbers did not facilitate reliable examination of heterogeneity.  Examination of the 
funnel plots highlights large confidence intervals and variability in effect sizes illustrating clinical and 
methodological heterogeneity respectively. The small number of studies within this review also 
meant that tests for publication bias could not be performed.  Ioannidis and Trikalinos (2007) 
recommend at least 10 trials for enough power to perform such analysis.  There were only 5 studies 
eligible for the meta-analysis and these were all with small samples (N range 27 – 66).    
Nevertheless, meta-analysis of small studies within a limited evidence base is advantageous as long 
as sensitivity analyses are considered (IntHoult et al., 2015).   
The comprehensive sythesis of a limited evidence base of internalised stigma interventions for 
schizophrenia-spectrum diagnosis was a considerable strength of the review.  The review 
synthesised data on outcome measures, key mechanisms of change within internalised stigma 
interventions, and meta-analysed a relatively large sample to identify effect sizes of internalised 
stigma interventions. This facilitated the identification of a number of recommendations for future 
trials of internalised stigma interventions. 
Future research 
In terms of the population examined, over half of the studies included in this review did not 
exclusively examine participants with a schizophrenia-spectrum diagnosis.  It would be important to 
examine the efficacy of an internalised stigma intervention in large scale RCTs exclusively with this 
presentation, such as people who experience first episode psychosis, severe and enduring psychosis, 
and at risk groups as stigma is a prevalent issue in all these groups (McCay et al., 2007; Morrison et 
al., 2015).    
The review tentatively suggests that the development of more targeted interventions for 
internalised stigma may be helpful.  The majority of interventions to date have not directly targeted 
internalised stigma idiosyncratically through the development of a formulation.  A number of large 
scale RCTs are required to examine the efficacy of the diverse psychosocial interventions included in 
this review.  All studies included in this review had relatively small sample sizes and did not have 
enough power to find significant results on the internalised stigma outcome.  All intervention types 
would benefit from further examination in a large-scale trial.  Potentially, one of the most important 
interventions to examine is CBT given that it is the first line recommended psychological intervention 
for people with a schizophrenia-spectrum diagnosis(NICE, 2014).  As stated, psychoeducation, 
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normalisation, and cognitive restructuring of stigma were the most frequently used change 
mechanisms with study interventions, all of which are encompassed within a CBT approach. 
The refinement and validation of an internalised stigma outcome measure which is specific to 
people with a schizophrenia-spectrum diagnosis and meets all reliability and validity (Terwee et al., 
2007) could also improve outcome. As Brohan et al (2010b) stated, there is not a measure of 
internalised stigma which meets all reliability and validity criteria required for an outcome measure.  
Being able to identify the efficacy of an internalised stigma intervention would depend on a measure 
which is sensitive and specific to change.   Best practise also states that outcome measures should 
also be developed in consultation with service users (Trivedi and Wykes, 2002). 
In conclusion, internalised stigma interventions could show promise in alleviating internalised stigma 
in people with a schizophrenia-spectrum diagnosis.  However the studies were limited by the small 
sample size, small effect sizes, and the lack of methodological rigor in some of the studies included in 
the review.  Further large-scale RCTs need to be conducted in order to examine the efficacy of 
internalised stigma interventions exclusively with people with a schizophrenia-spectrum diagnosis.  
Outcome measures should include measures of internalised stigma, recovery, self-esteem, 
empowerment, self-efficacy, and coping skills.    
Schizophrenia Research 176(2-3):291-303 Oct 2016 
18 
 
References 
Amador, X.F., Strauss, D.H., Yale, S.A., Flaum, M.M., Endicott, J., Gorman, J.M., 1993. The assessment 
of insight in psychosis. The American Journal of Psychiatry 150(873 - 879). 
Armiji-Olivo, S., Stiles, C.R., Hagen, N.A., Biondo, P.D., Cummings, G.G., 2012. Assessment of study 
quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the 
Effective Public Health Practice Project Quality Assessment tool: methodological research. . Journal 
of Evaluation  in Clinical Practice 18(1), 12- 18. 
Beck, A., Weissman, A., Lester, D., Trexler, L., 1974. The measurement of pessimism: The 
Hopelessness Scale. Journal of Consulting and Clinical Psychology 42, 861-865. 
Beck, A.T., Ward, C.H., Mendelson, M., Mock, J.E., Erbaugh, J., 1961. An inventory for measuring 
depression. Archives of General Psychiatry 4(561 - 571). 
Birchwood, M., Smith, J., Drury, V., Healy, J., MacMillan, F., Slade, M., 1994. A self-report insight 
scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatria Scandanavica 89(1), 
62 - 67. 
Borenstein, M., Hedges, L., Higgins, J.P.T., Rothstein, H., 2009. Comphrensive Meta-Analysis. Biostat, 
New Jersey. 
Brohan, E., Elgie, R., Sartorius, N., Thornicroft, G., 2010a. Self-stigma, empowerment and perceived 
discrimination among people with schizophrenia in 14 European countries: The GAMIAN-Europe 
study. Schizophrenia Research 122(1-3), 232-238. 
Brohan, E., Slade, M., Clement, S., Thornicroft, G., 2010b. Experience of mental illness stigma, 
prejudice and discrimination: a review of measures. BMC Health Services Research 10. 
Chiu, F.P.F., Tsang, H.W.H., 2004. Validation of the Chinese General SElf-efficacy Scale among 
individuals with schizophrenia in Hong Kong. International Journal of Rehabilitation Research 27, 159 
- 161. 
Colliver, J.A., Kucera, K., Verhulst, S.J., 2008. Meta-analysis of quasi-experimental research: are 
systematic narrative reviews indicated? Medical Education 42(9), 858-865. 
Cook, D.R., 1987. Measuring shame: The internalised shame scale. Alcoholism Treatment Quarterly 
4(2), 197 - 215. 
Corrigan, P., Watson, A., 2002. The paradox of self-stigma and mental illness. Clinical Psychology: 
Science and Practice 9, 35 - 53. 
Corrigan, P.W., Morris, S., Larson, J.E., Rafacz, J., Wassel, A., Michaels, P., Wilkniss, S., Batia, K., 
Rusch, N., 2010. Self-stigma and coming out about one's mental illness. Journal of Community 
Psychology 38(3), 259 - 275. 
Dinos, S., Stevens, S., Serfaty, M., Weich, S., King, M., 2004. Stigma: the feelings and experiences of 
46 people with mental illness. British Journal of Psychiatry 184, 176 - 181. 
Edwards, J.R., Baglioni, A.J., 1993. The measurement of coping with stress: construct validity of the 
Ways of Coping Checklist and the Cybernetic Coping Scale. Work Stress 7(17-31). 
Endicott, J., Spitzer, R., Fleiss, J., Cohen, J., 1976. The Global Assessment Scale: A procedure for 
measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33, 766 - 771. 
Evans, C., Mellor-Clark, J., Margison, F., Barkham, M., Audin, K., Connell, J., McGrath, G., 2000. CORE: 
Clinical Outcomes in Routine Evaluation. Journal of Mental Health 9(3), 247 - 255. 
Fitts, W.H., Warren, W.L., 1996. Tennessee Self-Concept Scale. Los Angeles, Western Psychological 
Services. 
Fung, K.M.T., Tsang, H.W.H., Cheung, W., 2011. Randomized controlled trial of the self-stigma 
reduction program among individuals with schizophrenia. Psychiatry Research 189, 208 - 214. 
Fung, K.M.T., Tsang, H.W.H., Corrigan, P.W., Lam, C.S., Cheung, W., 2007. Measuring self-stimga of 
mental illness in China and its implications for recovery. International Journal of Social Psychiatry 
53(408 - 418). 
Goffman, E., 1963. Stigma: notes on the management of spoiled identity. Harmondsworth, 
Middlesex: Penguin Books. 
Schizophrenia Research 176(2-3):291-303 Oct 2016 
19 
 
Griffiths, K.M., Carron, A., B., Parsons, A., Reid, R., 2014. Effectiveness of programs for reducing the 
stigma associated with mental disorders. A meta-analysis of randomized controlled trials. World 
Psychiatry 13, 161 - 175. 
Henrichs, D., Hanlon, T., Carpenter, W., 1984. The quality of life scale: An instrument for rating the 
schizophrenic deficit syndrome. Schizophrenia Bulletin 10(3), 388 - 396. 
Higgins, J.P.T., Altman, D.G., Gotzsche, P.C., Juni, P., Moher, D., Oxman, A.D., Savovic, J., Schulz, K.F., 
Weeks, L., Sterne, J.A.C., 2011. The Cochrane Collaboration’s tool for assessing risk of bias in 
randomised trials. Research Methods & Reporting, 1-9. 
Higgins, J.P.T., Green, S., 2011. Cochrane Handbook for Systematic Review of Interventions. The 
Cochrane Collaboration, London. 
Hilburger, J., 1995. Stages of change in reasiness for rehabilitation services among people with 
severe mental illness. DIssertation Abstracts International 56, 2886. 
Hogan, T.P., Awad, A.G., Eastwood, R., 1983. A self-report scale predictive of drug compliance in 
schizophrenics: reliability and discriminative validity. Psychological Medicine 13(177 - 183). 
Holzinger, A., Beck, M., Munk, I., Weithaas, S., Angermeyer, M.C., 2003. Stigmas perceived by 
schizophrenics and depressives. Psychiatric Practice 30(7), 395-401. 
Hutton, P., Taylor, P.J., 2014. Cognitive behavioural therapy for psychosis prevention: a systematic 
review and meta-analysis. Psychological Medicine 44(3), 449 - 468. 
IntHoult, J., Ioannidis, J.P.A., Borm, G.F., Goeman, J.J., 2015. Small studies are more heterogeneous 
than large ones: 
a meta-meta-analysis. Journal of Clincal Epidemiology 68, 860-869. 
IntHout, J., Ioannidis, J.P., Borm, G.F., 2012. Obtaining evidence by a single well-powered trial or 
several modestly powered trials. Methods and Medical Research. 
Ioannidis, J.P.A., Trikalinos, T.A., 2007. The appropriateness of asymmetry tests for publication bias 
in meta-analyses: a large survey. Canadian Medical Association Journal 176(8), 1091 - 1096. 
Karidi, M.V., Vassilopoulou, D., Savvidou, E., Vitoratou, S., Maillis, A., Rabavilas, A., Stefanis, C.N., 
2015. Bipolar disorder and self-stigma: A comparison to schizophrenia. Journal of Affective Disorders 
184(208-215). 
Kay, S.R., Fiszbein, A., Opler, L.A., 1987. The positive and negative syndrome scale (PANSS) for 
schizophrenia. Schizophr Bull 13(2), 261-276. 
King, M., Sokratis, D., Shaw, J., Watson, R., Stevens, S., Passetti, F., Weich, S., Sefaty, M., 2007. The 
Stigma Scale: development of a standardised measure of the stigma of mental illness. British Journal 
of Psychiatry 190, 248 - 254. 
Knight, M.D., Wykes, T., Hayward, P., 2006. Group treatment of perceived stigma and self-esteem in 
schizophrenia: A waiting list trial of efficacy. Behavioural and Cognitive Psychotherapy 34, 305 - 318. 
Law, H., Neil, S.T., Bunn, G., Morrison, A., 2014. Psychometric properties of the Questionaire about 
the Process of Recovery (QPR). Schizophrenia Research 156(2), 184 - 189. 
Lazarus, R.S., Folkman, S., 1984. Stress, Appraisal and Coping. Springer. 
Lecomte, T., Corbiere, M., Laisne, F., 2006. Investigating self-esteem in individuals with 
schizophrenia: Relevance of the Self-Esteem Rating Scale-Short Form. Psychiatry Research 143, 99-
108. 
Lecomte, T., Cyr, M., Lesage, A.D., Wilde, J., Leclere, C., Ricard, N., 1999. Efficacy of a self-esteem 
module in the empowerment of individuals with schizophrenia. The Journal of Nervous and Mental 
Disease 187, 406 - 413. 
Link, B.G., Mirotznik, J., Cullen, F.T., 1991. The effectiveness of stigma coping orientations: Can 
negative consequences of mental illness labelling be avoided? Journal of Health and Social Behavior 
32(3), 203 - 320. 
Link, B.G., Stuening, E.L., Neese-Todd, S., Asmussen, S., Phelan, J., 2002. On describing and seeking 
to change the experience of stigma. Psychiatric Rehabilitation Skills 6, 201-231. 
Schizophrenia Research 176(2-3):291-303 Oct 2016 
20 
 
Livingston, J.D., Boyd, J.E., 2010. Correlates and consequences of internalized stigma for people 
living with mental illness: A systematic review and meta-analysis. Social Science & Medicine 71(12), 
2150-2161. 
Lucksted, A., Drapalski, A., Calmes, C., Forbes, C., DeForge, B., Boyd, J., 2011. Ending Self-Stigma: 
Pilot Evaluation of a New Intervention to Reduce Internalized Stigma Among People with Mental 
Illnesses. Psychiatric Rehabilitation Journal 35, 51-54. 
Lundberg, B., Hansson, L., Wentz, E., Bjorkman, T., 2008. Stigma,discrimination, empowerment and 
social networks: a preliminary investigation of the influence on subjective quality of life in a Swedish 
sample. International Journal of Social Psychiatry 54(47-55). 
Luoma, J.B., Kohlenberg, B.S., Hayes, S.C., Fletcher, L., 2012. Slow and steady wins the race: a 
randomized clinical trial of acceptance and commitment therapy targeting shame in substance use 
disorders. Journal of Consulting and Clinical Psychology 80(1), 43-53. 
Maeda, M., Mukasa, H., Ogoh, J., Mukasa, H., 1992. Psychoeducational meeting for the 
schizophrenia patients. Japanese Clinical Psychiatry 21, 1195 - 1202. 
Mansell, W., 2007. An Integrative Formulation-Based Cognitive Treatment of Bipolar Disorders: 
Application and Illustration. Journal of Clinical Psychology 83(5), 447 - 481. 
Mattick, R.P., Clarke, J.C., 1998. Development and validation of measures of social phobia scrutiny 
fear and social interaction anxiety. . Behavior Research and Therapy 36, 455-470. 
McCay, E., Beanlands, H., Zipursky, R., Roy, P., Leszcz, M., Landeen, J., Ryan, K., Conrad, G., Romano, 
D., Francis, D., Hunt, J., Costantini, L., Chan, E., 2007. A randomised controlled trial of a group 
intervention to reduce engulfment and self-stigmatisation in first episode schizophrenia. Australian 
e-ournal for the Advancement of Mental Health 6(3), 1-9. 
McCay, E.A., Seeman, M.V., 1998. A scale to measure the impact of a schizophrenia illness on an 
individual's self-concept. Acrhives of Psychiatric Nursing 7, 41-49. 
Miller, J.F., Powers, M.J., 1988. Development of an instrument to measure hope. Nursing Research 
37, 6-10. 
Mittal, D., Sullivan, G., Chekuri, L., Allee, E., Corrigan, P.W., 2014. Empirical studies of self-stigma 
reduction strategies: A critical review of the literature. Psychiatric Services 63(10), 974 - 981. 
Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., The PRISMA group, 2009. Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses: The PRISMA Statemen. Annals of Internal Medicine 
151(4). 
Morrison, A., Barratt, S., 2010. What are the components of CBT for psychosis? A delphi study. 
Schizophrenia Bulletin 36(1), 136-142. 
Morrison, A., Burke, E., Murphy, E., Pyle, M., Bowe, S., Varese, F., Dunn, G., Chapman, N., Hutton, P., 
Welford, M., Wood, L., in press. Cognitive Therapy for Internalised Stigma in People Experiencing 
Psychosis: A pilot randomised controlled trial. Psychiatry Research. 
Morrison, A., Burke, E., Murphy, L., Pyle, M., Bowe, S., Varese, F., Chapman, N., Hutton, P., Welford, 
M., Wood, L., 2015. Cognitive Therapy for Internalised stigma in people with psychosis: A pilot 
randomised controlled trial. Behaviour Research and Therapy. 
Morrison, A., Renton, J., French, P., Bentall, R., 2008. Think you're crazy? Think again: a resource 
book for cognitive therapy for psychosis. 
Morrison, A.P., 2001. The interpretation of intrusions in psychosis: An integrative cognitive approach 
to hallucinations and delusions. Behavioural and Cognitive Psychotherapy 29, 257-276. 
Neil, S., Pitt, L., Kilbride, M., Morrison, A.P., Nothard, S., Welford, M., Selwood, W., 2009. The 
Process of Recovery Questionniare (QPR). Psychosis 1(1-11). 
NICE, 2014. Psychosis and schizophrenia in adults: treatment and management. National Institute of 
Clinical Excellence, London. 
Oliveria, S.E., Esteves, F., Carvalho, H., 2015. Clinical profiles of stigma experiences, self-esteem and 
social relationships among people with schizophrenia, depressive and bipolar disorders. Psychiatry 
Research doi: 10.1016/j.psychres.2015.07.047. 
Schizophrenia Research 176(2-3):291-303 Oct 2016 
21 
 
Popay, J., Roberts, H., Sowden, A., Petticrew, M., Arai, L., Rodgers, M., Britten, N., Roen, K., Duffy, S., 
2006. Guidance on the Conduct of Narrative Synthesis in Systematic Reviews - A Product from the 
ESRC Methods Programme. ESRC Methods Programme, Lancaster. 
Priebe, S., Huxley, P., Knight, S., 1999. Application and result of the Manchester Short Assessment of 
Quality of Life(MANSA). International Journal of Social Psychiatry 45(1), 7-12. 
Radloff, L.S., 1977. The CES-D scale: a self report depression scale for research in the general 
population. Applied Psychological Measurement 1, 385 - 401. 
Ritscher, J.B., Phelan, J., 2004. Internalised stigma predicts erosion of morale among psychiatric 
outpatients. Psychiatry Research 129, 257 - 265. 
Ritsher, J.B., Otilingam, P.G., Grajales, M., 2003. Internalized stigma of mental illness: psychometric 
properties of a new measure. Psychiatry Research 121, 31 - 49. 
Roe, D., Hasson -Dhayon, I., Mashiach-Eizenberg, M., Derhy, O., Lysaker, P.H., Yanos, P.T., 2014. 
Narrative Enhancement and Cognitive Thearpy (NECT) Effectiveness: A quasi-experimental study. 
Journal of Clinical Psychology 70(4), 303 - 312. 
Rogers, E.S., Chamberlin, J., Ellison, M.L., Crean, T., 1997. A consumer constructed scale to measure 
empowerment among users of mental health services. Psychiatric Services 48, 1042-1047. 
Rosenberg, M., 1979. Conceiving the Self. New York, Basic Books. 
Rusch, N., Abbruzzese, E., Hagedom, E., Hartenhauer, D., Kaufmann, I., Curschellas, J., Ventling, S., 
Zuaboni, G., Bridley, R., Olschewski, M., Kawohl, W., Rossler, W., Kleim, B., Corrigan, P.W., 2014. 
Efficacy of coming out proud to reduce stigma's impact among people with mental illness: pilot 
randomised controlled trial. British Journal of Psychiatry 204, 391 - 397. 
Russinova, Z., Rogers, E.S., Gagne, C., Bloch, P., Drake, K.M., Mueser, K.T., 2014. A Randomized 
Controlled Trial of a Peer-Run Antistigma Photovoice Intervention. Psychiatric Services 65, 242 - 246. 
Sarisoy, G., Kacar, O.F., Pazvantoglu, O., Korkmaz, I.Z., Ozturk, A., Akkaya, D., Yilmaz, S.B., 2013. 
Internalized stigma and intimate relations in bipolar and schizophrenic patients: a comparative 
study. Comprehensive Psychiatry 54(6), 665-672. 
Scwarzer, R., Jerusalem, M., 1995. Generalized self-efficacy scale; in Measures in Health Psychology: 
A User’s Portfolio. Nfer-Nelson, Windsor, UK. 
Sherer, M., Maddux, J.E., Mercandante, B., Prentice-Dunn, S., Jacobs, B., Rogers, R.W., 1982. The 
self-efficacy scale : Construction and validation. . Psychological Reports 51, 663 - 671. 
Snyder, C.R., Harris, C., Anderson, J.R., Holleran, S.A., Irving, L.M., Sigmon, S.T., 1991. The will and 
the ways: Development and validation of an individual-differences measure of hope. Journal of 
Personality and Social Psychology 60, 570-585. 
Sousa, S.D., Marques, A.J., Queiros, C., 2012. How to reduce self-stigma in schizophrenia? An 
intervention through sociodrama and e-learning, 20th European Congress of Psychiatry, Prague, 
Czech Republic. 
Terwee, C.B., Bot, S.D.M., de Boer, M.R., Windt, D., Knol, D.L., Dekker, J., 2007. Quality criteria were 
proposed for measurement properties of health status questionnaires. Journal of Clinical 
Epidemiology 60, 34 - 42. 
Trivedi, P., Wykes, T., 2002. From passive subjects to equal partners: Qualitative review of user 
involvement in research. British Journal of Psychiatry 181(6), 468-472. 
Uchino, T., Maeda, M., Uchimura, N., 2012. Psychoeducation may reduce self stigma of people with 
Schizophrenia and Schizoaffective Disorder. Kurumo Medical Journal 50(25-31). 
Whatley, C.D., 1959. Social attitudes towards discharged mental patients. Social Problems 6(313 - 
320). 
Winter, L.B., Steer, R., Jones-Hicks, L., Beck, A.T., 1999. Screening for major depressive disorder in 
adolescent medical outpatients with the Beck Depression Inventory for Primary Care. Journal of 
Adolescent Health 24, 389 - 394. 
Wood, L., Birtel, M., Alsawy, S., Pyle, M., Morrison, A., 2014. Public perceptions of stigma towards 
people with schizophrenia, depression, and anxiety. Psychiatry Research 220(1), 604-608. 
Schizophrenia Research 176(2-3):291-303 Oct 2016 
22 
 
Wood, L., Burke, E., Byrne, R., Morrison, A., in press. Examining service user experiences of a 
Cognitive Therapy intervention for self-stigma in psychosis. Psychosis: Psychological, social and 
integrative approaches. 
Wood, L., Burke, E., Morrison, A., in prep. The development and validation of the Semi-structured 
Interview measure of Stigma (SIMS) in Psychosis. 
Wykes, T., Parr, A.M., Landau, S., 1999. Group treatment of auditory hallucinations: exploratory 
study of effectiveness. British Journal of Psychiatry 175(180 - 185). 
Yanos, P.T., Knight, E.L., Bremer, L., 2003. A new measure of coping with symptoms for use with 
persons diagnosed with severe mental ilness. Psychiatric Rehabilitation Journal 27, 168 - 176. 
Yanos, P.T., Lucksted, A., Drapalski, A.L., Roe, D., Lysaker, P.H., 2014. Interventions Targeting Mental 
Health Self-stigma: A review and comparison. Psychiatric Rehabilitation Journal. 
Yanos, P.T., Roe, D., Lysaker, P.H., 2012. Narrative Enhancement and Cognitive Therapy: A new 
group-based treatment for internalised stigma among persons with severe mental illness. 
International Journal of Group Psychotherapy 61(4), 576. 
Young, S.L., Ensing, D.S., Bullock, W.A., 1999. The mental health recovery measure. Department of 
Psychology, OH: University of Toledo. 
Zimet, G.D., Dahlem, N.W., Zimet, S.G., Farley, G.K., 1988. The multidimensional scale of perceived 
social support. Journal of Personality Assessment 52(1), 30-41. 
 
 
  
Schizophrenia Research 176(2-3):291-303 Oct 2016 
23 
 
Figure 1 –PRISMA diagram of search strategy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Electronic database searches 
(PsycInfo, Embase, and Medline) 
N = 1553 
Trials registry  (CENTRAL, 
clinicaltrials.gov) 
N = 1623 
 
 Number included from Electronic 
database search at title: 
Number included N = 77 
Number included from trial registry: 
N = 12 
 
Number excluded at text (including 
duplicates) from databases: 
N = 1486 
Number excluded at text (including 
duplicates) from trial registry: 
N = 1611 
 
Number excluded at abstract 
N = 60 
Number excluded at abstract: 
N = 9 
Number included from Electronic 
database search at abstract: 
Number included N = 17 
Number included from trial registry: 
N = 3 
 
Additional articles added: 
From included article reference = 1 
Suggested by included author = 1 
Articles included at full text: 
N =  10 
 
Reasons for exclusion 
<50% participants with psychosis 
N = 5 
Not a stigma specific intervention 
N = 4 
Study not completed 
N=1 
 
 
 
Final list of included articles: 
N = 12 (7 RCTs, 3 CSs, 2 CTs) 
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Randomised controlled trials Baseline demographics (total 
sample) 
 
Author Study 
design 
Intervention Number 
randomised  
Dropouts 
(at ET) 
Modality Sessions 
offered 
(weeks) 
Primary 
measure of 
self-stigma 
Location 
(city) 
Schizophrenia 
related 
Diagnosis, n (%) 
Age(years), 
Mean (SD) 
Female, n 
(%) 
 
Follow-
up data 
available 
Link et al (2002) RCT SPE 
Control 
88 
N/R 
18 (20.45%) Group 16  (8) PDD USA S, 36.4% 
NAP, 13.6% 
40.9 (n.s.) 34 (38.6%) B, ET, 18 
McKay et al (2007)* RCT MSI 
TAU 
41 
26 
12 (29.3%) 
8 (30.8%) 
Group 12 (12) MES Canada 
(Toronto) 
FEP 100% 25.07 (4.86) 
26.17 (7.03) 
9 (31.0%) 
4 (22.2%) 
B, ET 
Yanos et al (2011) RCT NECT 
TAU 
21 
18 
5 (23.8%) 
2 (11.1%) 
Group  20 (20) ISMI USA (New 
York, Indiana) 
S, 28.2%, SA, 
48.7% 
47.14 (7.86) 
48.06 (6.78) 
 7 (33.3%) 
4 (22.2%) 
B, ET, 3 
Fung et al (2011), Tsang et al 
(2014) 
RCT SSRP 
NRG 
34 
32 
0 (0.0%) 
2 (6.3%) 
Group 16, 12 group, 
4 1:1 (16) 
CSSMIS Hong Kong S 100% 43.91 (10.38) 
46.91 (8.92) 
16 (47.1%) 
13 (40.6%) 
B, ET, 2, 
4, 6 
Rusch et al (2014)** 
 
RCT COP 
TAU 
16 
11 
2 (12.5%) 
0 (0.0%) 
Group 3 (3) ISMI Switzerland 
(Zurich) 
SSD 100% 44.69 (11.62) 
38.36 (7.22) 
8 (50.00%) 
5 (38.46%) 
B, ET, 
3wk 
Russinova et al (2014)**  RCT API 
WLC 
14 
14 
1 (7.1%) 
2 (14.3%) 
Group 10 (10) ISMI USA SSD 100% 46.32 (12.66) 
48.14 (11.39) 
10 (71.4%) 
10 (71.4%) 
B, ET, 3 
Morrison et al (2015) RCT CBT 
TAU 
15 
14 
2 (13.3%) 
1 (7.1%) 
Individual 12  (16) ISMI-R UK 
(Manchester) 
S, 31%, FEP 47% 
RP 3% 
39.00 (13.50) 
29.36 (10.02) 
3 (20.0%) 
3 (21.4%) 
B, ET, 3 
Controlled trials and cohort studies Baseline demographics (total sample) 
Author Study 
design 
Intervention Number 
allocated 
Dropouts Modality Sessions 
offered 
(weeks) 
Primary 
measure of 
self-stigma 
Location 
(country) 
Schizophrenia 
related 
diagnosis, n (%) 
Age(years), 
Mean (SD) 
Female, n 
(%) 
Follow-
up data 
available 
Knight et al (2006) Time 
series 
CBT 
 
21 2 (9.5%) Group 7 (7) PDD UK (London) S 38.%, PS 
57.1%, SA 4.8% 
39.32 (8.79) 10 (47.6%) B, ET, 
6wk 
Lucksted et al (2011) Cohort ESS 50 16 (32.0%) Group 9 (9) ISMI USA S 41.17%, SA, 
8.82%, P 5.88% 
51.56 (7.18) 3 (18.8%) B, ET 
Sousa et al (2012)* Cohort SD&EL 21 4 (19.0%) Group 15 group, 15 
online 
ISMI Portugal S 100% 38.1 (8.7) 2 (11.77%) B, ET 
Uchino et al (2012) Controlle
d trial 
PE 
SC 
29 
27 
NR Group 6 (6) SDS-J Japan S 92.9%, SA, 
7.1% 
35.6(10.4) 
32.8 (10.5) 
NR ET 
Roe et al (2014)* 
 
Controlle
d trial 
NECT 
TAU 
137 
85 
74 (54.0%) 
29 (34.1%) 
Group 20 (20) ISMI Israel Author 
approximates 
majority 
39 (12.1) 
44 (12.3) 
33 (52%) 
32 (57%) 
B, ET 
Table 1 – studies included in the systematic review 
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CBT cognitive behaviour therapy, CCMIS  Chinese Version of the Self-stigma of Mental Illness Scale, COP coming out proud, DDS Devaluation-Discrimination Scale, ESS Ending Self-Stigma Intervention, ET end of 
therapy , FEP first episode psychosis, , ISE Index of Self Esteem, ISMI Internalised Stigma of Mental Illness Scale, , ISMI-R Internalised Stigma of Mental Illness Scale Revised, MSI Manualised stigma intervention, MES 
Modified Engulfment Scale, NAP Non-affective psychosis , NECT Narrative Enhancement Cognitive Therapy, N/R Not reported, NRG Newspaper Reading group, PDD Perceived Devaluation and Discrimination Scale, 
PE Psychoeducation,  , RP recurrent psychosis, SA schizoaffective disorder, SC Standard care, SDS-J Social Distance Scale Japan, SSRP Self-stigma reduction programme,  TAU treatment as usual, WLC Waiting list 
control, S Schizophrenia 
*Baseline demographics do not include drop outs, **Data reported is only for the participants diagnosed with a schizopreniform diagnosis. 
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Table 2 – Assessment of bias 
W – Weak, M-Moderate, S-Strong 
 
 
Study Selection Bias Study design Confounders Blinding Data collection 
methods 
Withdrawals 
/drop outs 
Global rating 
Randomised controlled trials   
Link et al (2002) M (2) S (1) W(3) W(3) S (1) M (2) W(3) 
McKay et al (2007) M (2) S (1) S (1)         M (2) S (1) S (1) S (1) 
Yanos et al (2011) M (2) S (1) S (1) S (1) S (1) M (2) S (1) 
Fung et al (2011), Tsang et al (2014) M (2) S (1) S (1) M (2) S (1) S (1) S (1) 
Rusch et al (2014) M (2) S (1) S (1) M (2) S (1) S (1) S (1) 
Russinova et al (2014)  M (2) S (1) S (1) M (2) S (1) S (1) S (1) 
Morrison et al (2015) S (1) S (1) S (1) S (1) S (1) S (1) S (1) 
Controlled trials and cohort studies 
Lucksted et al (2011) M (2) W(3) W(3) W(3) S (1) M (2) W(3) 
Sousa et al (2012) M (2) W(3) W(3) W(3) S (1) S (1) W(3) 
Uchino et al (2012)       M (2) M (2) W(3) W(3) S (1) M (2) W(3) 
Knight et al (2006) M (2) W(3) W(3) W(3) S (1) S (1) W(3) 
Roe et al (2014) 
 
M (2) M (2) W(3) W(3) S (1) W(3) W(3) 
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Table 3 – Outcomes measured and tools used 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PDD – Perceived Devaluation-Discrimination scale (Link et al., 1991; Link et al., 2002),  SRER – Self-Reported Experiences of Rejection (Link et al., 2002) , SRF – Stigma Related Feelings (Link et al., 2002), MES - 
Modified Engulfment Scale (McCay and Seeman, 1998)   ISMI -  Internalised Stigma of Mental Illness Scale (Ritscher and Phelan, 2004), CSSMIS – Chinese Self-Stigma of Mental Illness Scale (Fung et al., 2007), KSS – 
A
u
th
o
r 
Se
lf
-s
ti
gm
a 
G
e
n
e
ra
l s
ti
gm
a
 
St
ig
m
a 
St
re
ss
 
C
o
p
in
g 
sk
ill
s 
R
e
co
ve
ry
  
Fu
n
ct
io
n
in
g 
P
sy
ch
o
p
at
h
o
lo
gy
 
D
e
p
re
ss
io
n
 
H
o
p
el
e
ss
n
e
ss
 
A
n
xi
e
ty
 
Se
lf
-E
st
ee
m
 
Em
p
o
w
e
rm
en
t 
Se
lf
-e
ff
ic
ac
y 
Sh
am
e
 
K
n
o
w
le
d
ge
 
Tr
e
at
m
e
n
t 
ad
h
e
re
n
ce
 
In
si
gh
t 
So
ci
al
 S
u
p
p
o
rt
 
C
h
an
ge
 
To
ta
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Link et al 
(2002) 
PDD 
SRF 
SRER 
 
 
- 
ACWS -  - CESD - - RSES - - - - - - - - 6 
McKay et al 
(2007) 
MES 
PDD 
 - -  QLS 
GAF 
PANSS - MHS - RSES TSCS SES - - - - - - 9 
Yanos et al 
(2011) 
ISMI - - CSC  QLS PANSS - BHS - RSES - - - - - SUMD - - 7 
Fung et al 
(2011), Tsang 
et all (2014) 
CSSM
IS 
- - - -   - - - - - CGSS - - - SUMD - CAQ 4 
Rusch et al 
(2014) 
ISMI 
 
- SS LSS 
COMIS 
-  - - - - - RES - - - - - - - 5 
Russinova et al 
(2014) 
ISMI - - ACWS PGRS  - CESD - - - RES SES - - - - - - 6 
Morrison et al 
(2015) 
ISMI 
SIMS 
KSS - - QPR-S  - 
 
BDI-PC BHS SIAS SERS - - ISS - - - - - 9 
Controlled trials and cohort studies 
Lucksted et al 
(2011) 
ISMI - - - MHRM  - - - - - RES - - - - - PSS - 4 
Uchino et al 
(2012) 
SDS - - -  GAF - - - - - - - - KIDI DAI BPIS - - 5 
Sousa et al 
(2012) 
ISMI - - -  CORE (F) CORE (S) - - - - - - - - - - - - 2 
Knight et al 
(2006) 
PDD - - CCS -  PANSS BDI - - ISE RES - - - - - - - 6 
Roe et al 
(2014) 
ISMI - - -  MANSA - - ADHS - RSES - - - - - - - - 4 
N (%) studies 
examining 
outcome 
12 
(100) 
2  
(16.7) 
1 
(8.3) 
5  
(41.7) 
3 
(25) 
5 
(41.7) 
 
4 
(33.3) 
4 
(33.3) 
4 
(33.3) 
1 
(8.3) 
6 
(50) 
5 
(41.7) 
3  
(25) 
1  
(8.3) 
1 
(8.3) 
2  
(16.7) 
3  
(25) 
1 
(8.3) 
1 
(8.3) 
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King Stigma Scale (King et al., 2007), SIMS – Service user Interview Measure of Stigma (Wood et al., in prep), SDS – Social Distance Scale (Whatley, 1959),  ACWS – Approaches to Coping with Stigma (Link et al., 2002), 
CSC- Coping with Symptoms Checklist (Yanos et al., 2003), LSS – Link Secrecy Scale (Link et al., 2002), COMIS – Coming Out with Mental Illness Scale (Corrigan et al., 2010), CCS – Cybernetic Coping Scale (Edwards and 
Baglioni, 1993), QLS – Quality of Life Scale (Henrichs et al., 1984), GAF – Global Assessment of Functioning (Endicott et al., 1976), PGRS – Personal Growth and Recovery Scale (Russinova et al., 2014), QPR-S – Process 
of Recovery Short Form (Law et al., 2014),  MHRM – Mental Health Recovery Measure (Young et al., 1999), CORE – Clinical Outcome and Routine Evaluation Measure (Evans et al., 2000), MANSA – Manchester Short 
Assessment of Quality of Life (Priebe et al., 1999), PANSS – Positive and Negative Syndrome Scale (Kay et al., 1987), CESD – Centre of Epidemiological Studies Depression (Radloff, 1977), BDI-PC – Beck Depression 
Inventory for Primary Care (Winter et al., 1999), BDI – Beck Depression Inventory (Beck et al., 1961), MHS – Miller Hope Scale (Miller and Powers, 1988), BHS – Beck Hopelessness Scale (Beck et al., 1974), ADHS – 
Adult Dispositional Hope Scale (Snyder et al., 1991),  SS – Stigma Stress Scale (Lazarus and Folkman, 1984), SIAS – Social Interaction Anxiety Scale (Mattick and Clarke, 1998), RSE – Rosenberg Self-Esteem Scale 
(Rosenberg, 1979), SERS – Self-Esteem Rating Scale (Lecomte et al., 2006), TSCS – Tennessee Self-Concept Scale (Fitts and Warren, 1996), RES – Rogers Empowerment Scale (Rogers et al., 1997), Self-Efficacy Scale 
(Sherer et al., 1982), CGSS – Chinese General Self Efficacy Scale (Chiu, 2004), GSES – General Self-Efficacy Scale (Scwarzer and Jerusalem, 1995), ISS – Internalised Shame Scale (Cook, 1987), KIDI – Knowledge of 
Illness and Drugs Inventory (Maeda et al., 1992), DAI – Drug Attitude Inventory (Hogan et al., 1983), SUMD – Scale to Assess Unawareness of Mental Disorders (Amador et al., 1993), BPIS – Birchwood Psychosis 
Insight Scale(Birchwood et al., 1994), PSS – Perceived Social Support (Zimet et al., 1988), CAQ – Change Assessment Questionnaire (Hilburger, 1995). 
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NA-Data not in published paper as study used <50% people with psychosis, NR – Not reported, - Significant result favouring stigma intervention,  - non significant difference, - outcome not examined 
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Link et al (2002)        - - - NR - - NR - - - 
McKay et al (2007)  - -  NR  - - NR NR NR - 
Yanos et al (2011)   -   -  -  - -  
Fung et al (2011)  - - - - - - -  -   
Rusch et al (2014)   - - - - - -  -  - - 
Russinova et al (2014)    - -  - - -   - 
Morrison et al (2015)  -  - -     - - - 
Controlled trials and cohort studies  
Lucksted et al (2011)  -  - - - - - -  - - 
Uchino et al (2012)  
 
- -  - - - - - - -  
Sousa et al (2012)  - -   - - - - - - - 
Knight et al (2006)   - -   - -   - - 
Roe et al (2014) 
 
 - -  - -  -  - - - 
Table 4 – Significant outcomes (total scores) of self-stigma intervention end of therapy 
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Figure 2 – Internalised Stigma (IS) meta-analysis output for end of therapy 
 
Figure 3 – Internalised Stigma (IS) meta-analysis output for follow-up 
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Figure 4 – Random effects model of secondary outcomes at end of therapy 
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Figure 5 - Random effects model of secondary outcomes at follow-up 
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Figure 6 - Random effects model of insight at end of therapy 
 
Figure 7 - Random effects model of insight at follow-up 
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Appendix 1- Excluded studies at full text  
 Shimostsu, S., Horikawa, N., Emura, R., Ishikawa, S., Nagao, A., Ogata, A., Hiejima, S., 
Hosomi, J. (2014)  Effectiveness of group cognitive-behavioural therapy in reducing self-
stigma in Japanese Psychiatric Patients.  Asian Journal of Psychiatry, 10, 39 – 44 
Reason for exclusion:  Not examining intervention with people diagnosed with a 
schizophrenia-spectrum diagnosis 
 Brown, S. (2010) Implementing a brief hallucination simulation as a mental illness stigma 
reduction strategy.  Community Mental Health Journal, 46, 500 – 504 
Reason for exclusion:  Not examining intervention with people diagnosed with a 
schizophrenia-spectrum diagnosis 
 Michaels, P., Corrigan, P.W., Buchholz, B., Brown, J., Arthur, T., Netter, C., MacDonald-
Wilson, K. (2014) Changing stigma through a consumer-based stigma reduction program.  
Community Mental Health Journal, 50, 395-401.   
Reason for exclusion:  Intervention was implemented with those who have severe mental 
illness and did not report diagnosis.  Corresponding author contacted (13/12/2014) via email 
to ask if they were able to give diagnosis data.  Author reported that this data was not 
collected and therefore publication does not meet criteria of ≥50% people who have a 
schizophreniform diagnosis. 
 Luoma, J.B., & Kohlenberg, B.S. (2011) Slow and Steady Wins the Race: A Randomized 
Clinical Trial of Acceptance and Commitment Therapy Targeting Shame in Substance Use 
Disorders.  Journal of Consulting and Clinical Psychology. 80, 1, 43-53. 
Reason for exclusion:  Not examining intervention with people diagnosed with a 
schizophrenia-spectrum diagnosis 
 Sibitz, I., Provaznikova, K., Lipp, M., & Lakeman, R. (2013) The impact of recovery-oriented 
day clinical treatment on internalized stigma: Preliminary report.  Psychiatry Research. 326-
332.   
Reason for exclusion: Intervention did not primarily focus on reducing internalised stigma. 
 Morrison, A.P., Birchwood, M., Pyle, M., Flach, C., Stewart, S., Byrne, R., Patterson, P., Jones, 
P.B., Fowler, D., Gumley, A.I., French, P. (2013) Impact of cognitive therapy on internalised 
stigma in people with at-risk mental states.  British Journal of Psychiatry. 203, 140 – 145 
Reason for exclusion: Intervention did not primarily focus on reducing internalised stigma. 
 Aho-Mustonen, K., Tiihonen, J., Repo-Tihonen, Ryynanen, P., Miettinen, R., Raty, H. (2011) 
Group psychoeducation for long-term offender patients with schizophrenia:  An exploratory 
randomised controlled trial.  Criminal Behaviour and Mental Health. 21, 163-176. 
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Reason for exclusion: Intervention did not primarily focus on reducing internalised stigma. 
 Shin, S., Lukens, E. (2002) Effects of psychoeducation for Korean Americans with chronic 
mental illness.  Psychiatric Services. 53 (9), 1125 – 1131. 
Reason for exclusion: Intervention did not primarily focus on reducing internalised stigma. 
 MacInnes, D.L., & Lewis, M. (2008) The evaluation of a short group programme to reduce self-
stigma in people with serious and enduring mental health problems. Journal of Psychiatric & Mental 
Health Nursing, 15, 59 – 65 
Reason for exclusion: Author was contacted via email on three occasions but no response received.  
Therefore we were unable to ascertain whether ≥50% of participants had a schizophreniform diagnosis. 
 Lucksted, A (ongoing) Ending Self Stigma: Randomized Trail to Reduce Internalized Stigma 
among People with SMI 
Reason for exclusion:  Trial not yet complete. 
 
